1.
Haemophilia
; 28(4): e101-e104, 2022 07.
Article
in English
| MEDLINE
| ID: mdl-35279924
2.
J Pediatr Hematol Oncol
; 44(3): 100-102, 2022 Apr 01.
Article
in English
| MEDLINE
| ID: mdl-35319503
ABSTRACT
Postsolid organ transplant Burkitt lymphoma (PSOT-BL) is rare but more aggressive than other post-transplant lymphoproliferative disorders (PTLD). Little is known about optimal treatment and outcome of postcardiac transplant Burkitt lymphoma (BL). We report an 8-year-old boy with a history of heart transplant who developed Epstein-Barr virus positive, late-onset PSOT-BL. He was successfully treated with BL specific chemoimmunotherapy and cessation of baseline immunosuppression. In this pediatric case of PSOT-BL, the use of standard intensive pediatric based chemoimmunotherapy regimen without modifications was feasible, well tolerated and resulted in complete remission. Long-term toxicities need further study.
Subject(s)
Burkitt Lymphoma , Epstein-Barr Virus Infections , Heart Transplantation , Lymphoproliferative Disorders , Burkitt Lymphoma/drug therapy , Burkitt Lymphoma/therapy , Child , Epstein-Barr Virus Infections/complications , Heart Transplantation/adverse effects , Herpesvirus 4, Human , Humans , Lymphoproliferative Disorders/drug therapy , Male
3.
J Nucl Med
; 63(1): 167-168, 2022 01.
Article
in English
| MEDLINE
| ID: mdl-33990401